Eisai and Biogen Initiate BLA in China for Alzheimer’s Therapy Lecanemab
Japan-based Eisai Co., Ltd (TYO: 4523) and its US co-development partner Biogen Inc. (NASDAQ: BIIB)...
Chronic disease
Sibionics Raises RMB 500 Million in Series D Financing Round
Shenzhen-based chronic disease device maker Sibionics has reportedly raised close to RMB 500 million (USD...
PingAn Good Doctor Partners to Establish Lifestyle Medicine
China-based PingAn Healthcare and Technology Co., Ltd (HKG: 1833), also known as PingAn Good Doctor,...
Innovent Biologics Collaborates with LG Chem for Tigulixostat in China
China-based Innovent Biologics (HKG: 1801) has announced a strategic collaboration and license agreement with South...
4B Technologies Raises RMB 100M in Pre-Series B Financing Round
China-based 4B Technologies Investments Ltd, a biotech focused on central nervous system (CNS) drug development,...
Biogen’s Aducanumab Administered to Chinese Patient for First Time
US major Biogen’s (NASDAQ: BIIB) Alzheimer’s disease (AD) therapy aducanumab has been administered to a...
Luye Pharma Group Hands Over Seroquel Distribution Rights to DCH Auriga in Singapore
China-based Luye Pharma Group announced that it is handing Singapore distribution and marketing rights to...
Luye Pharma Partners with Nhwa and Fine Hin to Commercialize Toludesvenlafaxine
China-based Luye Pharma Group (HKG: 2186), Jiangsu Nhwa Pharmaceutical Co., Ltd (SHE: 002262), and Beijing...
CSL Vifor and Fresenius Kabi Win China Approval for Ferinject
Swiss firm CSL Vifor and Germany’s Fresenius Kabi have announced the first regulatory approval in...
Luye Pharma Launches Toludesvenlafaxine in China for Depression Treatment
China-based Luye Pharma Group (HKG: 2186) has officially launched its Category 1 chemical drug toludesvenlafaxine...
Hong Kong Researchers Identify New Target for Epilepsy Treatment
Researchers at the University of Hong Kong have published the results of a study that...
Nuance Pharma Partners with DKSH to Launch Bentrio Nasal Spray in Hong Kong and Macau
China-based Nuance Pharma has announced a partnership with DKSH Hong Kong Business Unit Healthcare to...
Visen Pharmaceuticals Files for Hong Kong IPO with Focus on Growth Hormone
Visen Pharmaceuticals, a China-based joint venture between Denmark-headquartered Ascendis Pharma and Chinese healthcare-focused investment firm...
JD Healthcare Partners with Jiangsu Yuyue for Medical Device Collaboration
JD Healthcare, a unit of China’s e-commerce giant JD.com (NASDAQ: JD), has announced a partnership...
Wolters Kluwer Partners with China’s NCID to Advance Infectious Disease Diagnosis
Holland-based information and software solutions provider Wolters Kluwer has announced a partnership with China’s National...
Hengrui Pharmaceuticals Receives Clinical Trial Approvals for Three New Drugs
China-based Jiangsu Hengrui Pharmaceuticals (SHA: 600276) has announced receiving clinical trial approvals for three in-house...
Haisco’s HSK31858 Gains Ethical Approval for Phase II Study in NCFBE
China-based Haisco Pharmaceutical Group Co., Ltd (SHE: 002653) has announced that its drug candidate HSK31858...
Simcere Pharmaceuticals Licenses Idorsia’s Insomnia Therapy Daridorexant for Greater China
China-based Simcere Pharmaceutical Group (HKG: 2096) has announced the establishment of a licensing agreement with...
Haisco’s HSK16149 Accepted for Review by NMPA for Diabetic Neuropathic Pain
China-based Haisco Pharmaceutical Group Co., Ltd (SHE: 002653) has announced that a market approval filing...
Cowell Health Partners with AstraZeneca to Enhance Cancer Care at CIIE
Cowell Health has announced a partnership with UK-based AstraZeneca (AZ, NASDAQ: AZN) at the 5th...